Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05565807 · RECRUITING
Trial details
- NCT number
- NCT05565807
- Sponsor
- Zhejiang ACEA Pharmaceutical Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2026-12-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.